middle.news
How EBR Systems Plans to Revolutionize Heart Failure Treatment with WiSE CRT
8:38am on Wednesday 13th of August, 2025 AEST
•
Healthcare
Read Story
How EBR Systems Plans to Revolutionize Heart Failure Treatment with WiSE CRT
8:38am on Wednesday 13th of August, 2025 AEST
Key Points
FDA approval granted for WiSE CRT System, the first leadless left ventricular pacing device
First commercial implants completed at leading US medical centers
Medicare NTAP and preliminary TPT reimbursement approvals effective October 2025
A$75.9 million capital raise completed to fund commercialization efforts
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ebr Systems (ASX:EBR)
OPEN ARTICLE